<<
>>

1. .., .., .. . ( ). .: , 2000. - 80 .

2.

.., .. // . 1997. . 3. . 20-21.

3. .. . .: , 1999. 596 .

4. .., .., .. // . 1999. . 39, 10. . 27-31.

5. ... // . 1998. . 70, 4. . 74-80.

6. .. - . .: , 1996. 784 .

7. .., .., .., .. .

// . 1999. 8. . 10-12.

8. . ., .., .. . // ( ). ., 2000. . 97-98.

9. . ., .., .. . // -2000 ( ). ., 2000.-. 429.

10. .., .. // . .: , 2001. . 126-140.

11. .., .. .

.: , 2001. 167 .

12. .., .., . . .: , 1999. 140 .

13. .., .., .. . // - . 2001. . 3. . 81.

14. .., .., .. . // - . 2001. . 3. . 81.

15. .., .., .. . ( )// . 1996. T9. . 55- 59.

16. . . () // . 1996. . 10. . 37-41.

17. . .: , 1976. 307 .

18. .., .. // . 2000. . 3. . 36-41.

19. .., .. . .: , 2000. 160 .

20. .., .., .., .. // .

1997. . 3. . 21-22.

21. - . : , 1998. 125 .

22. .., .., .. . // . 1997. . 69, 11. . 62-65.

23. .., .. : . .: , 2002. 183 .

24. .. - - // .

1997. . 3. . 22-23.

25. ., .., .. . . ( ) //. 1999. . 1. . 25-30.

26. .., .. : // . 1998. . 9. . 53-57.

27. .. // . 2000. . 9. . 5-15.

28. Aaronson N.K. Quality of life assessment in clinical trials: methodologic issues//Control Clin. Trials. 1989. Vol. 10. P. 195-208.

29. Aaronson N.K., Cull A., Kaasa S., Sprangers M. The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology// Int. J. Ment. Health. 1994. Vol. 23. P. 75-96.

30. Andrews F.M., Withey S.B. Social Indicators of well-being: Americans Perceptions of Life Quality. New-York: Plenum Press, 1976. 220 p.

31. Austin J.K., Smith M.S., Risinger M.W., McNelis A.M. Childhood epilepsy and asthma: comparison of quality of life // Epilepsia. - 1994. Vol. 35, 3. P. 608-615.

32. Baker E, Intagliata J. Quality of life in the evaluation of community support systems // Evaluat. Progr. Plann. 1982. Vol. 5. P. 69-79.

33. Bartman B.A., Rosen M.J., Bradham D.D etal. Relationship berween health status and utility measures in older clauducants // Qual. Life Res. 1998. Vol. 7. P. 67-73.

34. Bell M.J., Bombardier C., Tugwell P. Measurement of functional status, quality of life, and utility in rheumatoid arthritis // Arthritis and Rheumatism. 1990. Vol. 33, 4. P. 591-600.

35. Bjorner J.B., Thunedborg ., KristensenT.S. etal. The Danish SF-36 Health Survey: translation and preliminary validity studies / / J. Clin. Epidemiol. 1998. Vol. 51, 11. P. 991-999.

36. Boekhorst P.A., Schipperus M.R., Samijn J.P. et al. Total Body Irradiation(TBI) and high-dose chemotherapy in multiple sclerosis (MS) using rigorously T-cell depleted marrow drafts // Blood.

2001. Vol. 98, 11. Part 1. P. 688.

37. Bone M.R. International efforts to measure health expectancy // J. Epidemiol, and Community Health. 1992. Vol. 46. P. 555-558.

38. Bonomi A.E., Celia D.F., Hahn E.A. et al. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) Quality of Life Measurement System // Qual. Life Res.

1996. Vol. 5. P. 1-12.

39. Borgaonkar E., Irvine E.J. Quality of life measurement in gastrointestinal and liver disorders // Gut. 2000. Vol. 47, 3. P. 444-454.

40. Boulay F.M., David P.P, Bourassa M.G. Strategies for improving the work status of patients after coronary artery bypass surgery//Circulation. 1982. Vol. 66, Suppl. 3. P. 43-49.

41. Bousquet J., Burtin B., Chicoye A., Richard A. From genetics to quality of life // The optimal treatment and management of asthma. Ed. Chanez P, Bousquet J., Mishel F.B., Godard P. Seattle, 1996. P. 215-218.

42. Bowling A. Measuring Disease: a review of disease-specific quality of life measurement scales. Buckingham: Open University Press, 1996. 208 p.

43. Bowling A. Measuring Disease: a review of disease-specific quality of life measurement scales. Open University Press: Philadelphia, 1996. 374 p.

44. Bowling A. Measuring Health: a review of quality of life measurement scales // 2nd edition. Open University Press: Philadelphia, 1997. 160 p.

45. Bruil J., Maes S., Le Coq L., Boeke J. The development of the How Are You? (HAY), a quality of life questionnaire for children with a chronic illness // Quality of Life News Letter. 1997. Vol. 3. P. 9.

46. BuddG.T. Palliative chemotherapy of adult soft tissue sarcomas //Semin. Oncol. 1995. Vol. 22, Suppl. 3. P. 30-34.

47. Bullinger M., Alonso J., ApoloneG. etal. Translating health status questionnaires and evaluating their quality: The International Quality of Life Assessment Project approach // J. Clin. Epidemiol. 1998. Vol. 51, 11. P. 913-923.

48. Bullinger M., Power M.J., Aaronson N.K. et al. Creating and evaluating cross-cultural Instruments // Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd edition. Philadelphia: Lippincott-Raven Publishers, 1996. P. 659-668.

49. Bullinger M., Ravens-Sieberer U. Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results // Qual. Life Res. 1998. Vol. 7, 5. P. 399-407.

50. Burt R.K., Cohen B.A., OyamaY etal. Immune suppressive therapy with autologous hematopoietic stem cell transplantation arrests active CNS inflammation but not axonal atrophy in patients with severe disability and progressive multiple sclerosis // Blood. 2001. Vol. 98, 11. Part 1. P. 687.

51. Caine N., Harrison S.C.W., Sharpies L.D. et al. Prospective study of quality of life before and after coronary artery bypass grafting//BMJ. 1991. - Vol. 302, 2. - P. 511-516.

52. Campbell D.T., Fiske D.W. Convergent and discriminant validation by the multitrait multimethod matrix // Psychological Bulletin. 1959. Vol. 56. P. 81-105.

53. Celia D.F. Manuel: Functional Assessment of Cancer Therapy (FACT) // Scales. NY 1992.

54. Celia D.F., Dineen K., Arnason B. Validation of the functional assessment of multiple sclerosis quality of life instrument // Neurology. 1996. Vol. 47. P. 179-193.

55. Celia D.F., Fairclough D., Bonomi P. et al. Quality of life in advance non-small cell lung cancer: results from Eastern Cooperative Oncology Group Study 5592 // Proc. ASCO.

1997. P. 100-110.

56. Coates A.S. Quality of life and supportive care // Support Care Cancer. Vol. 5. P. 435-438.

57. Coates A.S., Byrne M., Bishop J.F. et al. Intermittent vs. continuous chemotherapy for breast cancer//N. Engl. J. Med. 1988. Vol. 318. P. 1468.

58. Coates A.S., Gebski V, Bishop J.F. et al. Improving the quality of life in advanced breast cancer. A comparison of continuous and intermittent treatment strategies // N.

Engl. J. Med. 1987. Vol. 317. P. 1490-1495.

59. Coates A.S., Gebski V., Signorini D. et al. For the Australian New Zealand Breast Cancer Trials Group. Prognostic value of quality of life scores during chemotherapy for advanced breast cancer//J. Clin. Oncol. 1992. Vol. 10. P. 1833-1838.

60. Coates A.S., Gebski V., Signorini D. et al. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer//J. Clin. Oncol. 1992. 10. P. 1833-1838.

61. Coates A.S., Porzsolt F., Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy // Eur. J. Cancer. 1997. Vol. 33. P. 1025-1030.

62. Cohen L., Littlefield C., Kelly P. et al. Predictors of quality of life and adjustment after lung transplantation // Chest. 1998. Vol. 113. P. 633-644.

63. Cohen S.B., Woolley J.M., Dallas W.W.C. et al. IL1-ra improves health-related quality of life as measured by the health assessment questionnaire // Arthritis and Rheumatism Suppl. 2000. Vol. 9. P. 744.

64. Colman S.S., Rothermich B.A., Rowland C.R. et al. Application of the extended methodology among migraineurs: results from a clinical trial // Qual. Life Res. 2000. Vol. 9, 3. - P. 258.

65. Cornell C.E., Raczynski J.M., Oberman A. Quality of life after coronary revascularization procedures // Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd Ed., Eds. Spilker B. Philadelphia, Lippincott-Raven Publishers, 1996. P. 865-882.

66. Cossutta R., Masserini A.B., Colombelli P. et al. Evaluation of quality of life in patients with systemic sclerosis by the SF-36 questionnaire // Arthritis and Rheumatism. 2000. Vol. 9., Suppl. P. 776.

67. Cost-effectiveness in health and medicine / Ed. Gold M.R., Siegel J.E., Russel L.B., Weinstein M.C. Oxford University Press: New York, Oxford, 1996. 425 p.

68. Cronbach L.J. Coefficient alpha and the internal structure of tests //Psychometrica. 1951. Vol. 16, 3. P.297-334.

69. Curran D., Fayers P, Molenberghs G., Machin D. Analysis of incomplete quality of life data in clinical trials // Qual. Life

Assessment in Clinical Trials. Ed. M.J. Staquol. Oxfoid University Press: Oxford, New York, Tokyo, 1998. P. 249 2HQ.

70. Dancey J., Zee B., Osoba D. Quality of Irln seomu: nn independent prognostic variable in a general population of ciuicoi patients receiving chemotherapy // Can. Med. Assoc ,J.

1996. 10. P. 225-230.

71. Deustman N.N., Moser M.T. Measurement and nllnols on quality of life in diabetes type II under three treatment pinups // QuaL Res. 1997. Vol. 6, 7-8. P. 691 692

72. Douzdjian V., Ferrara D., Silvestri G. Treatment slialugios for insulin-dependent diabetiscs with ESRD: A cost ellnotivnnoss decision analysis model //Am. J. of Kidney Disease I99H Vol. 31, 5. P. 794-802.

73. Ehrlich G. E. Social, economic, psychological, and sexual outcomes in rheumatoid arthritis // The Amencan Journal ot Medicine. 1983. Vol. 30. P. 27-34.

74. Engblom E., Hamalainen H., Lind J. et at. Quality ot life during rehabilitation after coronary artery bypass suigoiy//Qual. Life Res. 1992. Vol. 1. P. 167-175.

75. Engstorm C.-R, Persson L.O., Larsson S. el al. I nog loim effects of a pulmonary rehabilitation programme in outpatients with chronic obstructive pulmonary disease: a iandomi/ed controlled study //Scand. J. Rehab. Med. 1999 Vol. 31.

P. 207-213.

76. Erickson P. Modeling health-related quality ot lile: I tie bridge between psychometric and utility-based measmes // J. of the National Cancer Institute. Monograph 20, 1996 P. 1/ 22.

77. Fairclough D. Method of analysis for longitudinal studies of health-related quality of life // Quality of Lite Assessment in Clinical Trials. Oxford University Press: Oxford, NewYoik, Tokyo,

1998. P. 227-247.

78. Fassas A., Passweg J., Anagnostopoulos A. et al. Hemopoetic stem cell transplantation for multiple sclerosis // Bone Marrow Transplantation. 2001. -Vol. 27, Suppl. I. P. 4.

79. Fawzy F.I., Fawzy N.W., Hyun C.S. et al. Malignant melanoma. Effects of an early structured psychiatric intervention, coping and affective state of recurrence and survival 6 years later // Arch. Gen. Psychiatry. 1993. Vol. 50. -P 681 689.

80. Fayers R, Aarson N., Bjordal K., Sullivan M. QLQ C-30 Scoring Manual / EORTC Study Group on Quality of Life. Brussels, 1995. 50 p.

81. Feeny D. Evaluation of HRQOL in special populations: children. Abstracts Issue 7th Annual Conference of the International Society for Quality of Life Research // Qual. Life Research. 2000. Vol. 9, . 3. P. 246.

82. Felson D.T., Anderson J.J., Boers M. et al. The American College of Rheumatology core set of disease activity measures for rheumatoid arthritis clinical trials // Arthritis and Rheumatism. 1993. Vol. 36. P. 729-739.

83. Finnerty J.P., Keeping I., Bullough I., Jones J. The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease // Chest. 2001. Vol. 119, . 6. P. 1927- 1940.

84. Fraser C.S.A., Dobbs H.J., Ebbs S.R. etal. Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs. epirubicin measuring quality of life // Br. J. Cancer.

1993. Vol. 67. P. 402-406.

85. French D.J., Carroll A., Christie M.J. Health-related quality of life in Australian children with asthma: lessons for the cross- cultural use of quality of life instruments//Qual. Life Research.

1998. Vol. 7, 5. P. 409-419.

86. Gandek B., Ware J. Methods for validating and norming translations of health status questionnaires: The IQOLA Project approach // J. Clin. Epidemiol. 1998. Vol. 51, 11. P. 953-959.

87. Ganz P.A., Lee J.J., Siau J. Quality of life assessment. An independent prognostic variable for survival in lung cancer // Cancer. 1991. Vol. 67. P. 3131-3136.

88. Gelber R.D., Godhirrsch A., Cole B.F. et al. A quality- adjusted time without symptoms or toxicity (Q-7WiST) Analysis of Adjuvant Radiation Therapy and Chemotherapy for resectable rectal cancer // J. of the National Cancer Institute. 1996. Vol. 88, 15. P. 1039-1045.

89. Gilliss C.L., Gortner S.R., Hauck W.W. et al. A randomized clinical trial of nursing care for recovery from cardiac surgery // Heart Lung. 1993. Vol. 22. P. 125-133.

90. Glise H, Hallerback , Wiklund I. Quality of Life: n reflection

of symptoms and concerns//Scand.J. Gastroenterol. 1996.

Vol. 221, Suppl. P. 14-17.

91. Greenberg G.R., Feagan B.G., Martin F. of al. Oial budesonide for active Crohns disease. Canadian Inflammatory Bowel Disease Study Group // The New England Journal of Medicine. 1994. Vol. 331, 1. P. 836-841.

92. Guillemin E, Challier B., Urlacher F. et al. Quality of life in ankylosing spondylitis: validation of the Ankylosing Spondylitis Arthritis Impact Measurement Scales 2, a Modified Arthritis Impact Measurement Scales questionnaire // Arthritis Care and Research. 1999. Vol. 12, 3. P. 157-163.

93. Guillemin E, Coste J., Pouchot J., et al. The AIMS2-SF // Arthritis and Rheumatism. 1997. Vol. 40, 7. P. 1267- 1274.

94. Guyatt G.H., Berman L.B., Townsend M. et al. A measure of quality of life for clinical trials in chronic lung disease // Thorax. 1987. Vol. 42. P. 773-778.

95. Hagell R, Sandlund B. Patients self-assessment of disease and symptom severity in Parkinsons disease // Qual. life Res. 2000. Vol. 9, 3. P. 285.

96. Hayabuchi N., Jingu K., Miyoshi M. etal. Radiotherapy and chemotherapy in stage I and II non-Hodgkins lymphomas of Waldeyers ring //J. Jpn.Soc. Cancer Ther. 1990. Vol. 25. P. 1428 -1436.

97. Hicks I.E., Lambert M.H., Gerber L.H. et al. Functional outcome update in patients with soft tissue sarcoma undergoing wide local excision and radiation (abstract) // Arch. Phys. Med. Rehabil. 1985. Vol. 66. - P. 543.

98. Hyland M. Antiasthma drugs: quality of life rating scales and sensitivity to longitudinal changes // PharmacoEconomics.

1994. Vol. 6. P. 325-329.

99. Hyland M.E., Crocker G.R. Validation of an asthma quality of life dairy in a clinical trials // Thorax. 1995. Vol. 50. P. 724-730.

100. Ingham J., Portenoy R.K. The measurement of pain and other symptoms / Doyle D., Hanks G.W.C., McDonald N. Oxford Textbook of Palliative Medicine. 2nd ed. Oxford University Press, 1998. P. 203-213.

101. Jacoby A. Epilepsy and the quality of everyday life: findings from a study of people with well-controlled epilepsy // Soc. Sci. Med. 1992. Vol. 43, 6. P. 657-666.

102. JacoxA., CarrD.B., Payne R. etal. Management of Cancer Pain. Clinical Practice Guideline 9 // Rockville: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, 1994. Publications 94-0592.

103. Jensen MP, Karoly P. Measurement of Cancer pain Via Patient Self-Report / Current and Emerging issues in Cancer Pain: Research and Practice. Eds. Chapman C.R., Foley K.. Lippincott-Raven, 1993. P. 200-230.

104. Jerkeman M., Kaasa S., Kvaloy S. et al. Health-related quality of life, as assessed by the EORTC QLQ C30 (v 1.0), in patients with aggressive lymphomas treated with CHOP or MACOP-B in a multicentre randomized trial by the Nordic Lymphoma Group //Ann. Oncol. 1998. Vol. 9., Suppl. 4. Abstr. 5190.

105. Joly F., Henry-Amar M., Arveux P. et al. Late psychosocial sequelae in Hodgkins disease survivors: a French population- based case control study // J. Clin. Oncol. 1996. Vol. 14, 9. P. 2444-2453.

106. Juniper E.F. Quality-of-life considerations in the treatment of asthma / Quality of life assessment. Disease States. Ed. Kluwer W. Auskland, New Zealand, 1999. P. 69-86.

107. Juniper E.F., Guyatt G.H., Willan A., Griffith L.E. Determining a minimal change in a disease-specific quality of life questionnaire//J. Clin. Epidemiol. 1994. Vol. 47, 1. P. 81-87.

108. Kaasa S., Mastekaasa A., Lund E. Prognostic factors for patients with inoperable non-small lung cancer, limited disease. The importance of patients subjective experience of disease and psychosocial well-being. // Radiother. Oncol. 1989. Vol.15.-P 235-242.

109. Kashyap J., Passweg J., Fassas A. et al. Conditioning regimen intensity and transplant related mortality in patients treated for autoimmune diseases by autologous stem cell transplantation // Bone Marrow Transplantation. 2001. -Vol. 27, Suppl. 1. P. 4.

110. Kazis L.E., Anderson J.J., Meenar R.F. Effect sizes for interpreting changes in health status//Medicine Care. 1989. Vol. 27, Suppl. P. 178-189.

111. Kind P. Measuring quality of life in children / Assessment of Quality of Life in Childhood Asthma. Eds. Christie M., French D. Harwood Academic Publishers, Switzerland, 1994. P. 107-117.

112. Kvien T.K., Kaasa S., Smedstad L.M. Performance of the Norwegian SF-36 health survey in patients with rheumatoid arthritis II. A comparison of the SF-36 with Disease-Specific Measures // J. Clin. Epidemiol. 1998. Vol. 11. P. 1077- 1086.

113. Landgraf J.M., Abetz L.N. Measuring health outcomes in pediatric populations: issues in psychometric and application / Quality of Life and Pharmacoeconomics in clinical trials. 2nd Ed., Eds. Spilker B. Philadelphia, Lippincott-Raven Publishers, 1996. P. 793-802.

114. Landgraf J.M., Abetz L., Ware J.E. The Child Health Questionnaire (CHQ). A Users Manual / 2nd printing. Boston, MA: Health Act, 1999. 552 p.

115. Leplege A., Ecosse E., Verdier A., Perneger T. The French SF-36 Health Survey: Translation, Cultural Adaptation and Preliminary Psychometric Evaluation // J. Clin. Epidemiol. 1998. Vol. 51, N. 11. P. 1013-1023.

116. Lerner D. J., Amicklll . C., MalspeisS. etal. The angina- related limitations at work questionnaire // Qual. Life Res. 1998. Vol. 7, P 23-32.

117. Limbos M.M., Joyse D.P., Chan C.K.N., Kesten S. Psychological functioning and quality of life in lung transplant candidates and recipients // Chest. 2000. Vol. 118, 2. R 142-155.

118. Lopez-Vivancos J., Casellas F., Badia X. et al. Validation of the Spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohns disease // Digestion. 1999. Vol. 60. P. 274-80.

119. Malawer M.M., Buch R.G., Thompson W.E., Sugarbaker PH. Major amputation done with palliative intent in the treatment of local body complications associated with advanced cancer // J. Surg. Oncol. 1991. Vol. 47, 2. P. 121-130.

120. Markham A., Bryson H.M. Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications//Drugs. 1995. Vol. 42, 2. P. 232 254.

121. McMillan S.C., Mahon M. Measuring quality of life in hospice patients using a newly developed Hospice Quality of Life Index//Qual. Life Res. 1994. Vol. 3, 15. P. 437- 447.

122. McQuellon R.P., Craven B., Russell G.B. et al. Quality of life in breast cancer patients before and after autologous bone marrow transplantation // Bone Marrow Transplantation.

1996. Vol. 18. P. 579 584.

123. McQuellon R.P., Russell G.B., Celia D.F. et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale // Bone Marrow Transplantation.

1997. Vol. 19. P. 357 368.

124. McQuellon R.P., Russell G.B., RamboT.D. etal. Quality of life psychological distress of bone marrow transplant recipients: the time trajectory to recovery over the first year //Bone Marrow Transplantation. 1998. Vol. 21. P. 477-486.

125. Meenan R.F., Gertman P.M., Anderson J.J. et al. The content and properties of a revised and expanded arthritis impact measurement scales health status questionnaire // Arthritis and Rheumatism. 1992. Vol. 35, 1. P. 1-10.

126. Meenan R.F., Gertman P.M., Mason J.H., Dunaif R. The arthritis impact measurement scales // Arthritis and Rheumatism. 1992. Vol. 25, 9. P. 1048-1053.

127. Mendoza T.R., Wang X.S., Cleeland C.S. et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory // Cancer. 1999. Vol. 85, 5. P. 1186 1196.

128. Merinsky O., Kollender Y, Inbar M. et al. Palliative major amputation and quality of life in cancer patients // Acta Oncology. 1997. Vol. 36, 2. P. 151-157.

129. Morris A., Perez D., McNoe B. The use of quality of life data in clinical practice // Qual. Life Research. 1998. Vol.

7. -P.85-91.

130. Nash R.A., Bowen J.D., McSweeney P.A. etal. Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation // Blood. 2001. Vol. 98, N.11. Part 1. P. 687.

131. National Comprehensive Cancer Network Guideline for Cancer Pain. In The Complete Library of NCCN Oncology Practice Guidelines. NCCN Inc., 2000. 596 p.

132. Nielsen D., Sellgren J., Ricksten S.-E. Quality of life after cardiac surgery complicated by multiple organ failure // Critical Care Medicine. 1997. Vol. 25, 1. P. 51-58.

133. Nortvedt M.W., RiiseT., MyhrK.M. et al. Quality of life asa predictor for change in disability in MS // Neurology. 2000. Vol. 55, 12-1. P. 98-109.

134. Nortvedt M.W., Riise T, Myhr K.M. et al. Quality of life in multiple sclerosis: measuring the disease effects more broadly // Neurology. 1999. Vol. 22, 53-5. P. 1098-1103.

135. Novik A.A., Ionova T.I., Bisaga G.N. et. al. Quality of life improvement in patients with multiple sclerosis after autologous peripheral stem cell transplantation // Blood. 2001. Vol. 98, 11. Part 2. P. 396.

136. Novik A.A., Ionova T.I., Maximov A.G., Kovalenko A.N. Factors influencing quality of life in Non-Hodgkins lymphoma patients after conventional chemotherapy // Annals of Oncology. 1999. Vol. 10, Suppl. 3. P. 181.

137. Novik A., Ionova T, Povzun A., Maximov A. Fatigue as the most sensitive EORTC QLQ-C30 scale in lymphoma patients // Qual. Life Res. 1999. Vol.8, 7. P. 642.

138. Novik A.A., Ionova T.I., Povzun A.S. et al. Early impact of chemotherapy on quality of life of malignant lymphoma patients // Annals of Oncology. 2000. Suppl. 3. P. 182.

139. Novik A.A., Ionova T.I., Povzun A.S. et al. Quality of life of in patients with different types of leukemia // Qual. Life Res. 2000.-Vol. 9, 3. P. 294.

140. Novik A.A., Ionova T.I., Tzepkova A.A. et al. Quality of life of the population of St. Petersburg // Qual. Life Res. 2000. Vol. 9, 3. - P. 308.

141. Novik A.A., Trofimov V.I., Ionova T.l. et al. Quality of life dynamics in chronic bronchitis patients during conventional treatment // QOL Newsletter. 2001. Vol. 27. P. 11-12.

142. Nunnally J.C., Bernstein I.R. Psychometric Theory / 3th Edition. New-York, 1994. 243 p.

143. Osoba D., Brada M., Yung W.K., Prados M. Health-related quality of life in patients treated with temozolomide vs. procarbazine for recurrent glioblastoma miltiforme // J. Clin. Oncol. 2000. Vol. 18, 7. R 481-491.

144. Osoba D., Brada M., Yung W.K.A., Prados M.D. Health- related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide // Eur. J. Cancer. 2000. Vol. 36. P. 1788-1795.

145. Osoba D. Lessons learned from measuring health-related quality of life in oncology // J. Clin. Oncol. 1994. Vol. 12. P. 608-616.

146. Osoba D., Rodrigues G., Myles J. et al. Interpreting the significance of changes in health-related quality-of-life scores // J. Clin. Oncol. 1998. Vol. 16, 1. P 139-144.

147. Ott C., Bergner M. The effect of rehabilitation after myocardial infarction on quality of life // Qual. Life Cardiovasc. Care. 1985. Vol. 29. P. 176.

148. Palmer J.B., Hyland M.E. Salmetrol in clinical practice: comparator and safety studies, quality of life studies // Eur. Respir. Rev. 1991. Vol. 1. P. 101-103.

149. Perk J., Bedback B., Engvall J. Effects of cardiac rehabilitation after coronary artery bypass grafting on readmissions, return to work, and physical fitness // Scand. J. Soc. Med. 1990. Vol. 18. P. 45-51.

150. Petajan J.H., Gappmaier E., White A.T. et al. Impact of aerobic training on fitness and quality of life in multiple sclerosis // Ann. Neurol. 1996. Vol. 39. P. 432-441.

151. Plohmann A.M., Kappos L., Ammann W. etal. Computer assisted retraining of attentional impairments in patients with multiple sclerosis //J. Neurol. Neurosurg. Psychiatry. 1998. Vol. 64, 4. P. 455-462.

152. Pollard W.E., Bobbitt R.A., Berner M. et al. The sickness impact profile: reliability of a health status measure // Medical Care. 1976. Vol. 14. P. 146-155.

153. Raczynski J.M., Oberman A./Quality of life after coronary revascularization procedures. Quality of life and pharmacoeconomics in clinical trials. 2-nd edition, Philadelphia: New-York Lippincott-Raven, 1996. P. 865-882.

154. Quality of life and pharmacoeconomics in clinical trials / Ed. Spilker B. 2nd Edition. Philadelphia: New-York Lippincott- Raven, 1996. 1259 p.

155. Quality of life assessment in clinical trials / Ed. M.J. Staquet. Oxford University Press: Oxford, New York, Tokyo,

1998. 360 p.

156. Quality of life assessments in clinical trials / Ed. B. Spilker. New York, 1990. 24 p.

157. Ravens-Sieberer U., Bullinger M. Current approaches to measure the health-related quality of life in children // Quality of Life News Letter. 1997. Vol. 3. P. 12-13.

158. RenX.S., Kazis L., Meenan R.F. Short-form arthritis impact measurement scales 2: tests of reliability and validity among patients with osteoarthritis // Arthritis Care and Research.

1999. Vol. 12, 3. P. 163-173.

159. Revicki D. A. Relationship of pharmacoeconomics and health-related quality of life / Quality of life and pharmacoeconomics in clinical trials. Ed. Spilker B., 2nd edition. Philadelphia: Lippincott-Raven Publishers, 1996. P. 1077-1081.

160. Revicki D. A., Wood M., Maton P. N., Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life//The Am. J. of Medicine. 1998. Vol. 104. P. 252-258.

161. Revicki D.A., Wood M., Wiklund I., Crawley J. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease//Qual. Life Res. 1998. Vol. 7. P. 75-83.

162. Rice G.P., Oger J., Duquette P. et al. Treatment with interferon beta-1 b improves quality of life in multiple sclerosis // Can. J. Neurol. Sci. 1999. Vol. 26, 4. P. 276-282.

163. Rogers W. J., Coggin C. J., Gersh B. J. et al. Ten-Year follow-up of quality of life patients randomized to receive medical therapy or coronary artery bypass graft surgery // Circulation. 1990. Vol. 82, 5. P. 1647-1658.

164. Rosenbaum P.L., Sagal S. Measuring health-related quality of life in pediatric populations: conceptual issues / Qual. Life and Pharmacoeconomics in Clinical Trials. 2-nd edition. Philadelphia: Lippincott-Raven Publishers, 1996. P. 785-791.

165. Rumsfeld J.S., MacWhinney S., McCarthy M. Health- related quality of life as a predictor of mortality following coronary artery bypass graft surgery//JAMA. 1999. Vol. 281, 14. P. 1298-1303.

166. Schaysk C.P. Measurement of quality of life in patients with chronic obstructive pulmonary disease / Quality of life assessment. Disease States. Ed. Kluwer W. Auskland, New Zealand, 1999. P. 86-95.

167. Schwartz C.E., Coulthard-Morris L., Cole B. et al. The quality-of-life effects of interferon beta-1 b in multiple sclerosis. An extended Q-TWiST analysis // Arch. Neurol. 1997. Vol. 54. P. 1475-80.

168. Sedman A.D., Porteney R., Yao T.J. et al. Quality of life in Phase II Trials: a study of methodology and predictive value in patients with advance breast cancer treated with Paclitaxel plus granulocyte colony stimulating factor // J. Nat. Cancer Inst.

1995. Vol. 87. P. 1316 -1322.

169. Sharon A. Hunt. Current status of cardiac transplantation //JAMA. 1998. Vol. 280, N. 19. P. 1692-1698.

170. Shlenk E.A., Erlen J.A., Dunbar-Jacob J. et al. Health- related quality of life in chronic disorders: a comparison across studies using the MOS SF-36 // Qual. Life Res. 1998. Vol.

7. P. 57-65.

171. Sigle J.M., Porzsolt F. Practical aspects of quality of life measurement: design and feasibility study of the quality of life recorder and the standardized measurement of quality of life in an outpatient clinic // Cancer Treat. Rev. 1996. Vol. 22. P. 75-89.

172. Simes R.J., Gebski V, Coates A.S., Forbes J.F. Quality of life on single agent mitozantrone vs. cyclophosphamide, methotrexate, 5-fluorouracil, prednisone for advanced breast cancer (abstract) // Proc. Annu. Meet. Am. Soc. Clin. Oncol. 1994. Vol. 13. P. 73.

173. Sjoland H., Caidahl K., Wiklund I. et al. Impact of coronary artery bypass grafting on various aspects of quality

of life // Eur. J. Cardiothoracic Surg. 199/. Vol, II/, Nu4,

P. 612-619.

174. Smith D.F., BakerG.A., DaviesG. el nl. Oulenmwtiof add on treatment with lamotrigine in partial epilepsy // , 1993. Vol. 34. P. 312-322.

175. Solomon G.D., Litaker D.G. The imp,id nl diuu Ihnnipy on quality of life in headache and migraine / (jnnliiy uf life Assessment, Section 2: Disease States, I d Kliiwm W Auskland, New Zealand, 1998. P 19-2/.

176. Spertus J.A., Winder J.A., Dewhursl I A el nl Menlloilnu the quality if life in patients with coronary ailoiy disease // Am J. Cardiol. 1994. Vol. 74, 15. P 1240 1244

177. Spiegel D., Bloom J.R., Kraemer H.C el al I lie idled el psychosocial treatment on survival of patients with melnslnlk: breast cancer // Lancet. 1989. Vol. I' I

178. Squier H.C., Ries A.L., Kaplan R.M. el nl Uunlily el well

being predicts survival in lung transplantuhon candidates // Am. J. Respir. Crit. Care Med. 1995. Vol. I!>2 l20:i2 2036.

179. Stacey J.H., Miocevich M.L., Sacks ( I I lie elled el ranitidine on the quality of life of GORD pahenls // ϳ .I Cent. Pract. 1996. Vol. 50, 4. P. 190 194

180. Strauss W. E., Fortin T, Hartigan R el al A < ompaiisen el quality of life scores in patients with nny // cm i ilntii m 1995. Vol. 92, 7. P. 1710-1719.

181. SugarbakerP.H., Barofsky I., Rosenheiq!, . (,inneln I J. Quality of life assessment of patient in extremity s.m < unn < linical trials // Surgery. 1982. P. 13-23.

182. Sullivan . M. Long-term follow-up and < |ii.dil el hie alter

hematopoietic stem cell transplantation // I he .imirnnl el Rheumatology. 1997. Vol. 24. Suppl 4M I'46 92

183. Sullivan M., Karlsson J. The Swedish SI 361 lenllh: .nivoy

III. Evaluation of criterion-based validity: resells In normative population//J. Clin. Epidemiol. 1998. Vol M , I I* 1105-1113.

184. Tannock I.F., Boyd N.F., DeBoer G. el al A mndemi/ed trial of two dose levels of cyclophosphamide, 忳 >imato and fluorouracil chemotherapy for patients with meinsiniit Ineasl cancer//J. Clin. Oncol. 1988. Vol. 6. R // /

185. Tannock I.F., Osoba D., Stockier M.R.. Mitoxantrone // Journal of Clinical Oncology. 1996. 14. P. 1756-1764.

186. Tannock I.F. Treating the patient, not just the cancer // N. Engl. J. Med. 1987. Vol. 317. P. 1534-1535.

187. Tesar G.E., Hackett T.P. Psychologic management of the hospitalized cardiac patients // J. Cardiopulm. Rehabil. 1985. Vol. 5. P. 219.

188. The Canadian Burden of Illness Study Group. Burden of illness of multiple sclerosis: Part II: Quality of life//Can. J. Neurol. Sci. 1998. Vol. 25. P. 31-38.

189. The Writing Group for the Bypass Angioplasty Revascularization (BARI) Investigators. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease //JAMA. 1997. Vol. 277, 9. P. 715-721.

190. Theunissen N.C., Vogels T.G., Koopman H.M. The proxy problem: child report versus parent report in health-related quality of life research //Qual. Life Res. 1998. Vol. 7, 5. P. 387- 397.

191. Treatment of anemia in cancer. Recombinant human erythroietin r-HuEPO in the anemia of cancer // Bio-news Scientific. 1997. 25. P. 3-9.

192. Uematsu M., Kondo M., Hiramatsu H. etal. Stage IA Non- Hogdkins lymphoma of the Waldeyers ring //ActaOncologica. 1993. - Vol. 32, 6. P. 675-678.

193. Valenti L., Lim L., Heller R.F., Knapp J. An improved questionnaire for assessing quality of life after acute myocardial infarction // Qual. Life Res. 1996. Vol. 5. P. 151-161.

194. Varni J.W., Seid M., Kurtin P.S. Pediatric health-related quality of life measurement technology: a guide for health care decision makers//Journal of Clinical Outcomes Management.

1999. Vol. 6, 4. P. 33-40.

195. Varni J.W., Seid M., Kurtin P.S. The PedsQL 4.0 Measurement Model for the Pediatric Quality of Life Inventory Version 4.0 // Quality of Life News Letter. 1997. Vol. 3. P. 4-10.

196. Varni J.W., Seid M., Kurtin P.S. The PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory Version 4.0

Generic Core Scales in healthy and patient population!// Modlunl Care. 2001. Vol. 39, 8. P. 800-812.

197. VerdonckL.F., DekkerA.W., deGastG.C. nt bone marrow transplantation with a fixed low niimhin of f mul Pharmacoeconomics in Clinical Trials, 2nd minion Philadelphia, 1996. P. 883-890.

205. Whedon M., Stearns D., Mills L.E. Quality of lifn nt long term adult survivors of autologous bone marrow transpiunintion / /OncologyNursing Forum. 1995.Vol. 22, 10 l -2/ 1535.

206. Wiklund I.K. Hypertension. Quality ol lid- mul pharmacoeconomics in clinical trials, Ch. 92/2 ml ml Philadelphia, 1996. P. 893-901.

207. Wiklund I., Bardhan K.D., Muller-Lissner S. ut ul umiliiy of life during acute and intermittent treatment of gastrm -■ .< >i >i my ■ il reflux disease with omeprazol compared with ranitidm Hmmli-i from a multicentre clinical trial. The European Study Gmug // llnl J. Gastroenterol. Hepatol. 1998. Vol. 30, 1. I' I't

208. Williams A. Welfare economics and health status measurement / In Health, Economics and Health Economics, ed. J.van der Gaag and M.Perlman. AmsterdarmNorth Holland Publishing, 1981. P.123-32

209. Williams G. H.. Assessing patients wellness: new perspectives on quality of life and compliance//AJH. 1998. Vol. 11, 11-2. -P. 186-191.

210. WinninghamM.L., Nail L.M., Burke M.B. etal. Fatigue and the cancer experience: the state of the knowledge // Oncology Nursing Forum. 1994. - Vol. 21, 1. P. 23-36.

211. Wisloff F., Hjorth M. Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group // Br. J. Haematol. 1997. Vol. 97. -P. 29-37.

212. Wockel L., Meyer A.-E., SchweerD. etal. Quality of life in children and adolescents with mental disorders investigated by self- and observer- rating. // Qual. Life Res. 1999. Vol. 8, 7. P. 563.

213. World Health Organisation. Cancer pain relief. Geneva: WHO, 1986. - P. 5-26.

214. World Health Organization. Cancer pain relief and palliative care / Report of a WHO expert committee, WHO technical report series, 804. Geneva, 1990. P. 1-75.

215. Yellen S. B., Celia D. F., Bolomi A. Quality of life in people with Hodgkins disease // Oncology. 1993. Vol. 7. P. 41.

216. Yoshida T., Yoshida K., Yamamoto C. et al. Effects of a two- week, hospitalized phase II cardiac rehabilitation program on physical capacity, lipid profiles and psychological variables in patients with acute myocardial infarction // Jpn. Circ. J. 2001. Vol. 65, 2. - P. 87-93.

217. ZhaoS.Z., Fiechtner J. I., Tindall E. A. etal. Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxib//Arthritis Care and Research. 2000. Vol. 13, 2. P. 112-121.

<< | >>
: . ., . .. . 2- / .. . .., .: 2007. 2007

:

  1. :
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - -